Export

EN
FR
Sulfadoxine + pyrimethamine
Essential medicine status
Section:
6. Anti-infective medicines 6.5. Antiprotozoal medicines 6.5.3. Antimalarial medicines 6.5.3.1. Antimalarial medicines > For curative treatment
ATC codes: P01BD51
EMLc
Indication
Malaria due to Plasmodium vivax ICD11 code: 1F81
INN
Sulfadoxine + pyrimethamine
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Additional notes
Only in combination with artesunate 50 mg
Formulations
Oral > Solid: 500 mg + 25 mg tablet
EML status history
First added in 1979 (TRS 641)
Changed in 1987 (TRS 770)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 946)
Changed in 2007 (TRS 950)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Sulfadoxine + pyrimethamine
DrugBank
Sulfadoxine ,
Pyrimethamine
Summary of evidence and Expert Committee recommendations
Sulfadoxine + pyrimethamine tablets 500 mg + 25 mg was added to the EMLc for the curative treatment of malaria.